Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2741-2750 of 2762 for

Edit search filters
  1. Outcomes after Sacroiliac Resection for Pelvic Malignancy

    Rochester, MN

  2. Assessment of the Mechanical Properties of Lung Parenchyma using Magnetic Resonance Elastography in Lung Cancer

    Rochester, MN

  3. A Multi-Center Trial of the ProLung Test™

    Rochester, MN

  4. A Study of Biomarkers to Distinguish Benign from Cancerous Thyroid Tumors

    Rochester, MN

  5. Immune Control of Breast Cancer Tumor Dormancy

    Rochester, MN

  6. A Study to Validate An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test for Colorectal Cancer Screening

    Rochester, MN, Scottsdale/Phoenix, AZ

  7. A Study to Evaluate Heart Failure Biomarker to Predict Cardiomyopathy After Acute Radiation

    Jacksonville, FL

  8. Brain Imaging Changes Following Proton Therapy for Pediatric Primary Central Nervous System and Base of Skull Tumors

    Scottsdale/Phoenix, AZ

  9. Factors Contributing to Delay in Diagnosis of Bone/Soft Tissue Sarcoma

    Rochester, MN

  10. Therapeutic Drug Monitoring of Pembrolizumab and Nivolumab to Determine Dosages for Cancer Treatment

    Rochester, MN

.

Mayo Clinic Footer